RECRUITING

Cleveland African American Prostate Cancer Project

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to test intervention strategies that encourage and support Black or African American men who are 40 and older to complete prostate cancer screening, and specifically to complete a prostate-specific antigen (PSA) test.

Official Title

Cleveland African American Prostate Cancer Project: Equivalence of Passive Navigation, Active Navigation, and Community-based Screening for Completion of Prostate Cancer Screening

Quick Facts

Study Start:2023-06-09
Study Completion:2027-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05469269

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * ≥40 years old
  2. * Self-identify as Black or African American
  3. * Have a prostate gland (includes biological males, transwomen)
  4. * PSA-naïve or has not received a PSA test in the past 12 months
  5. * Has not had a previous prostate cancer diagnosis
  6. * English speaking
  7. * Ability to consent to study
  1. * Individuals who have had a prostatectomy

Contacts and Locations

Study Contact

Erika Trapl, PhD
CONTACT
216-368-8772
CAAPP@case.edu

Principal Investigator

Erika Trapl, PhD
PRINCIPAL_INVESTIGATOR
Case Comprehensive Cancer Center

Study Locations (Sites)

Barbershops Local to Cleveland
Cleveland, Ohio, 44106
United States

Collaborators and Investigators

Sponsor: Case Comprehensive Cancer Center

  • Erika Trapl, PhD, PRINCIPAL_INVESTIGATOR, Case Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-09
Study Completion Date2027-03-31

Study Record Updates

Study Start Date2023-06-09
Study Completion Date2027-03-31

Terms related to this study

Additional Relevant MeSH Terms

  • Prostate Cancer